{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10837989", "DateCompleted": {"Year": "2000", "Month": "07", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "70", "Issue": "3", "PubDate": {"Year": "2000", "Month": "Jun"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Hypnotic, anticonvulsant and muscle relaxant effects of Rubus brasiliensis. Involvement of GABA(A)-system.", "Pagination": {"StartPage": "275", "EndPage": "280", "MedlinePgn": "275-80"}, "Abstract": {"AbstractText": ["Rubus brasiliensis hexanic fraction induced anxiolysis in rodents, which was reversed by flumazenil, a specific GABA(A)-benzodiazepine receptor antagonist (Nogueira et al., 1998a,b). Then, we investigated if this hexanic fraction was able to induce hypnotic, anticonvulsant and muscle relaxant effects, and the involvement of GABA(A)-system. The hexanic fraction (50, 100, 150 and 300 mg/kg, vo) was administered to male Swiss mice, 30 min before the tests. Only the dose of 300 mg/kg of this fraction decreased the latency and increased sleeping time in the barbituric-hypnosis test (sodium pentobarbital, 30 mg/kg, ip), prevented the pentylenetetrazol seizures (70 mg/kg, ip) and induced muscle relaxant (inclined plane) in 100% of animals. These effects were reversed by flumazenil (3 mg/kg, ip).", "(1) R. brasiliensis hexanic fraction induced hypnotic, anticonvulsant and muscle relaxant effects, in mice, and the GABA(A)-benzodiazepine receptor may play an important role in the effects of this fraction; (2) it is strongly suggested that this fraction contains a benzodiazepine-like principle."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuropharmacology Laboratory, Centre of Toxicological Assistance, Bioscience Institute, UNESP, CEP: 18618-000, -SP, Botucatu, Brazil."}], "Identifier": [], "LastName": "Nogueira", "ForeName": "E", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Vassilieff", "ForeName": "V S", "Initials": "VS"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Barbiturates"}, {"RegistryNumber": "0", "NameOfSubstance": "GABA Modulators"}, {"RegistryNumber": "0", "NameOfSubstance": "Hexanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypnotics and Sedatives"}, {"RegistryNumber": "0", "NameOfSubstance": "Muscle Relaxants, Central"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, GABA-A"}, {"RegistryNumber": "40P7XK9392", "NameOfSubstance": "Flumazenil"}, {"RegistryNumber": "Q3JTX2Q7TU", "NameOfSubstance": "Diazepam"}, {"RegistryNumber": "WM5Z385K7T", "NameOfSubstance": "Pentylenetetrazole"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Barbiturates"}, {"QualifierName": [], "DescriptorName": "Brazil"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Diazepam"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flumazenil"}, {"QualifierName": ["pharmacology"], "DescriptorName": "GABA Modulators"}, {"QualifierName": [], "DescriptorName": "Hexanes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Hypnotics and Sedatives"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Muscle Relaxants, Central"}, {"QualifierName": [], "DescriptorName": "Pentylenetetrazole"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, GABA-A"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Seizures"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "6", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "7", "Day": "25", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "6", "Day": "6", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10837989", "10.1016/s0378-8741(99)00205-6", "S0378874199002056"]}}], "PubmedBookArticle": []}